Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease

NCT: NCT07618364 · RECRUITING

NCT IDNCT07618364
StatusRECRUITING
Start Date2022-01-01
Completion2027-12-01
SponsorRinsada (INDUSTRY)
First posted
Last updated

Brief Summary

The central hypothesis is that inflammation contributes to dry eye and that rinsing the palpebral conjunctiva, bulbar conjunctiva, and fornices will reduce the inflammatory burden on the ocular surface.

Frequently Asked Questions

What is The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease?

The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease is a clinical trial registered under NCT07618364. Current status: RECRUITING.

What is the status of NCT07618364?

The current status of NCT07618364 (The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease) is: RECRUITING.

When did The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease start?

The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease started on 2022-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑